ACSL4 and ablepharon macrostomia syndrome: These findings are consistent with the associations observed between salidroside and PSAP as well as ACSL4 in this study, indicating the identified biomarkers and their associated biological pathways can be molecular targets of TCM for AMS treatment and prevention [83].